Matches in Wikidata for { <http://www.wikidata.org/entity/Q58025659> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q58025659 description "article scientifique publié en 2004" @default.
- Q58025659 description "im November 2004 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58025659 description "wetenschappelijk artikel" @default.
- Q58025659 description "наукова стаття, опублікована в листопаді 2004" @default.
- Q58025659 name "Dose Seeking Evaluation of a Novel Heterologous Primeboost Immunotherapy in Stage III and IV Metastatic Melanoma Patients" @default.
- Q58025659 name "Dose Seeking Evaluation of a Novel Heterologous Primeboost Immunotherapy in Stage III and IV Metastatic Melanoma Patients" @default.
- Q58025659 type Item @default.
- Q58025659 label "Dose Seeking Evaluation of a Novel Heterologous Primeboost Immunotherapy in Stage III and IV Metastatic Melanoma Patients" @default.
- Q58025659 label "Dose Seeking Evaluation of a Novel Heterologous Primeboost Immunotherapy in Stage III and IV Metastatic Melanoma Patients" @default.
- Q58025659 prefLabel "Dose Seeking Evaluation of a Novel Heterologous Primeboost Immunotherapy in Stage III and IV Metastatic Melanoma Patients" @default.
- Q58025659 prefLabel "Dose Seeking Evaluation of a Novel Heterologous Primeboost Immunotherapy in Stage III and IV Metastatic Melanoma Patients" @default.
- Q58025659 P1433 Q58025659-CB01329B-9768-47C0-BA41-F66D0E3E52F6 @default.
- Q58025659 P1476 Q58025659-E5780563-FBDF-4F06-9816-0E4BAA43E4A2 @default.
- Q58025659 P2093 Q58025659-25A5A26C-4551-404B-A285-0453D1AF0EBD @default.
- Q58025659 P2093 Q58025659-47865622-4EFC-4402-8B61-1426C7AC5EBC @default.
- Q58025659 P2093 Q58025659-58386E5A-9C6F-42F5-A0FF-F16F3FA625D2 @default.
- Q58025659 P2093 Q58025659-81C45AF7-2AA4-4289-9F1A-90386173F054 @default.
- Q58025659 P2093 Q58025659-88E56849-B6C4-42BF-ADCA-7FC11EBFE5E2 @default.
- Q58025659 P2093 Q58025659-D5D8959A-14E3-467D-AEBF-70EA72F91B58 @default.
- Q58025659 P2093 Q58025659-D8881C65-F619-445D-A3E9-B768D5F09E0C @default.
- Q58025659 P304 Q58025659-534374CF-FCF2-474C-A8F3-63A06E101BEB @default.
- Q58025659 P31 Q58025659-9F73CB48-8700-4C43-9038-D42DB8EFC60C @default.
- Q58025659 P356 Q58025659-2C0C9B34-D720-492F-B550-101285642483 @default.
- Q58025659 P433 Q58025659-5BFA9A48-F8AE-498B-A390-A9A6CD7580A5 @default.
- Q58025659 P478 Q58025659-E3B02C44-7289-426E-AEB7-A9017C5B8A8C @default.
- Q58025659 P50 Q58025659-B6F0DA71-476A-48F9-9414-05B0B7FEFAD1 @default.
- Q58025659 P50 Q58025659-EA17577C-5AA9-4C44-A349-FF4E3BD497C7 @default.
- Q58025659 P50 Q58025659-FB16F0BF-AFE1-459F-A838-AFA883E061CE @default.
- Q58025659 P577 Q58025659-8982F7B3-2D98-46DD-89A4-CE62E2698C66 @default.
- Q58025659 P921 Q58025659-1231D2D5-AA7E-4596-9D70-2D5DFADFBE09 @default.
- Q58025659 P921 Q58025659-522B56E6-EBC1-4A37-8C53-765191080B1E @default.
- Q58025659 P356 00002371-200411000-00099 @default.
- Q58025659 P1433 Q15763946 @default.
- Q58025659 P1476 "Dose Seeking Evaluation of a Novel Heterologous Primeboost Immunotherapy in Stage III and IV Metastatic Melanoma Patients" @default.
- Q58025659 P2093 "Christian Ottensmeier" @default.
- Q58025659 P2093 "Frank Malinoski" @default.
- Q58025659 P2093 "Gillian Pearce" @default.
- Q58025659 P2093 "Joerg Schneider" @default.
- Q58025659 P2093 "John Smyth" @default.
- Q58025659 P2093 "Richard Anderson" @default.
- Q58025659 P2093 "Robert Hawkins" @default.
- Q58025659 P304 "S27" @default.
- Q58025659 P31 Q13442814 @default.
- Q58025659 P356 "10.1097/00002371-200411000-00099" @default.
- Q58025659 P433 "6" @default.
- Q58025659 P478 "27" @default.
- Q58025659 P50 Q107526958 @default.
- Q58025659 P50 Q32649390 @default.
- Q58025659 P50 Q37374768 @default.
- Q58025659 P577 "2004-11-01T00:00:00Z" @default.
- Q58025659 P921 Q1427096 @default.
- Q58025659 P921 Q18975855 @default.